|
Elliott Fineman, M.S., J.D., joined PLANET in 1998. He founded and served as Chief Operating Officer, Vice President and Director of Licensing and Intellectual Property of SuperGen, Inc., from January 1991 to August 1995. At SuperGen, he established facilities in Emeryville and Chicago, recruited the financial and operating management team, and assisted the CEO to develop overall company vision and strategy. He served as a general partner in two partnerships established to initially fund SuperGen's product development. He was instrumental in raising $15 million in early stage capital from private and corporate investors. In addition to Licensing and Intellectual Property responsibilities at SuperGen, he managed pre-clinical development for several products currently in clinical trials. He also contracted for sourcing several bulk drugs from China and Japan including doxorubicin, mitomycin C, daunorubicin, bleomycin, and paclitaxel and carried out GMP compliance audits for FDA approval in connection with Company ANDAs and INDs. From 1984 through 1991, Mr. Fineman held a series of positions of increasing responsibility at Cetus Corporation (later acquired by Chiron Corporation, Emeryville, CA) starting out as Senior Patent Attorney and ending as Director of Corporate Licensing. Prior to Cetus, he was a Senior Patent Attorney at Stauffer Chemical Company, with primary responsibility for agricultural biotechnology, and a patent Attorney in private practice. He holds a J.D. (1981) from the University of Baltimore where he served on the Law Review, an M.S. degree in Biology (1976) from Georgetown University where he was a University Fellow, and a BA with Honors in Biology (1972) from Oberlin College. | 